0001209191-13-055954.txt : 20131209
0001209191-13-055954.hdr.sgml : 20131209
20131209175125
ACCESSION NUMBER: 0001209191-13-055954
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131205
FILED AS OF DATE: 20131209
DATE AS OF CHANGE: 20131209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biota Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000072444
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 591212264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30009
BUSINESS PHONE: 301-770-3099
MAIL ADDRESS:
STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30009
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20100719
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20020304
FORMER COMPANY:
FORMER CONFORMED NAME: NABI /DE/
DATE OF NAME CHANGE: 19960405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Azzarello Peter
CENTRAL INDEX KEY: 0001591980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35285
FILM NUMBER: 131266537
MAIL ADDRESS:
STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-12-05
0
0000072444
Biota Pharmaceuticals, Inc.
BOTA
0001591980
Azzarello Peter
2500 NORTHWINDS PARKWAY, SUITE 100
ALPHARETTA
GA
30009
0
1
0
0
Chief Accounting Officer
Stock Option (Right to Buy)
4.13
2013-12-05
4
A
0
17500
0.00
A
2023-12-05
Common Stock
17500
17500
D
Market Stock Units
2013-12-05
4
A
0
4375
0.00
A
Common Stock
4375
4375
D
This option is a performance based option that will be 100% vested and exercisable upon hitting the primary endpoint for the Issuer's Phase 2 IGLOO trial on or before June 30, 2015, as determined by the Issuer's Compensation Committee in its sole discretion.
Each Market Stock Unit (MSU) represents a right to receive up to 2.5 shares of the Issuer's common stock. The vesting amount will be determined based on the twenty day trailing average stock price of the Issuer's common stock measured as of the last day of the performance period beginning on December 5, 2013 and ending on January 1, 2017.
Unless earlier forfeited under the terms of the MSU or accelerated upon a change of control transaction, each MSU vests and converts into no more than 2.5 shares of the Issuer's common stock on January 1, 2017.
/s/ Peter Azzarello
2013-12-09